Academic · Private company
Addario Lung Cancer Medical Institute
Track this companyFree. Adds Addario Lung Cancer Medical Institute to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)WITHDRAWN · started Sep 1, 2025ClinicalTrials.gov NCT07075627 · fetched Nov 12, 2026
- Small Cell Lung Cancer Community Engagement to Eliminate Research DiscepanciesACTIVE_NOT_RECRUITING · started May 23, 2025ClinicalTrials.gov NCT06486428 · fetched Nov 12, 2026
- Studying Pathways of Resistance in KRAS-driven CancersCOMPLETED · started Sep 8, 2022ClinicalTrials.gov NCT05272423 · fetched Nov 12, 2026
- Epidemiology of Young Lung Cancer - SurveyCOMPLETED · started Feb 1, 2021ClinicalTrials.gov NCT04640259 · fetched Nov 12, 2026
- Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based ChemotherapyTERMINATED · started Feb 1, 2021ClinicalTrials.gov NCT04676386 · fetched Nov 12, 2026
- Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK ResistanceCOMPLETED · started Jan 23, 2019ClinicalTrials.gov NCT03833934 · fetched Nov 12, 2026